低中危甲状腺癌全切术后未行碘131的甲状腺球蛋白切点研究
该多中心回顾性队列纳入9753例低中危分化型甲状腺癌全切未行RAI患者,在TSH抑制下于术后6、12、24个月用高敏法测非刺激Tg。Tg升高持续预测结构复发,最佳切点0.3 ng/mL;KTA的0.2与5.0 ng/mL切点具临床相关性,Tg动态变化可改善风险分层。
要点
- 术后非刺激Tg升高与结构复发风险相关,最佳切点为0.3 ng/mL。
- KTA生化缓解切点0.2 ng/mL对复发敏感性高,5.0 ng/mL独立预测复发风险升高。
- 即使Tg低于0.2或0.3 ng/mL,若随时间上升仍与复发相关。
核心结论
- 非刺激Tg水平与全切未行RAI的低中危DTC患者结构复发风险强相关。
- 现行0.2 ng/mL与5.0 ng/mL切点具临床相关性,Tg随时间动态变化可进一步改善风险分层。
研究设计与样本
- 回顾性分析9753例低中危DTC患者,均行甲状腺全切且未接受RAI,来自11家韩国三级医院。
- 术后6、12、24个月在TSH抑制(<2 mIU/L)下用高敏法(功能灵敏度<0.2 ng/mL)测血清Tg。
- 用ROC曲线与生存分析确定最佳Tg切点。
主要发现
- 术后非刺激Tg越高越持续预测结构复发,最佳切点0.3 ng/mL,6、12、24个月AUC分别为0.815、0.772、0.816。
- Tg≥0.2 ng/mL(KTA生化缓解即卓越反应切点)对复发显示高敏感性。
- 6个月时Tg≥5.0 ng/mL(KTA生化不完全反应阈值)独立预测复发风险升高。
- Kaplan-Meier曲线显示随Tg水平升高无复发生存呈阶梯式下降。
- 即使Tg<0.2或<0.3 ng/mL,若水平随时间上升仍与复发相关。
关键数值与推荐
- 最佳Tg切点0.3 ng/mL,6、12、24个月AUC分别为0.815、0.772、0.816。
- Tg检测在TSH抑制(<2 mIU/L)下进行,高敏法功能灵敏度<0.2 ng/mL。
- KTA生化缓解(卓越反应)切点0.2 ng/mL,生化不完全反应阈值5.0 ng/mL。
临床怎么用
- 对全切未行RAI的低中危DTC患者应早期并连续监测非刺激Tg。
- 可参照0.2、0.3与5.0 ng/mL切点分层,并关注Tg随时间的上升趋势。
局限性
- 为回顾性队列研究,来自韩国三级医院,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Background: The prognostic value of unstimulated serum thyroglobulin (Tg) levels for structural recurrence in patients with low- to intermediate-risk differentiated thyroid cancer (DTC) who underwent total thyroidectomy but did not receive radioactive iodine (RAI) therapy remains unclear. This study aimed to determine Tg cutoff values and evaluate the role of dynamic Tg monitoring in risk stratification in these patients. METHODS: We retrospectively analyzed 9753 patients with low- to intermediate-risk DTC who underwent total thyroidectomy without RAI at 11 Korean tertiary hospitals. Serum Tg levels were measured under thyrotropin suppression (<2 mIU/L) at 6, 12, and 24 months postoperatively using high-sensitive assays (functional sensitivity, <0.2 ng/mL). Optimal Tg cutoffs were determined by receiver operating characteristic curves and survival analyses. RESULTS: Higher postoperative unstimulated Tg levels consistently predicted structural recurrence, with an optimal cutoff of 0.3 ng/mL (area under the curve: 0.815, 0.772, and 0.816 at 6, 12, and 24 months, respectively). A Tg ≥ 0.2 ng/mL, the Korean Thyroid Association (KTA) guideline cutoff for biochemical remission (excellent response), showed high sensitivity for recurrence. Tg ≥ 5.0 ng/mL at 6 months, a KTA-defined threshold for a biochemical incomplete response, independently predicted an elevated recurrence risk. Kaplan-Meier curves showed stepwise declines in recurrence-free survival with increasing Tg levels. Notably, even Tg < 0.2 or < 0.3 ng/mL were associated with recurrence if levels rose over time. CONCLUSION: Unstimulated Tg levels are strongly associated with the risk of structural recurrence in patients with DTC who have undergone total thyroidectomy without RAI. The current cutoff values of 0.2 ng/mL and 5.0 ng/mL were clinically relevant, and Tg kinetics over time further improved risk stratification. These findings provide the first large-scale evidence from an East Asian cohort and underscore the importance of early, serial Tg assessment in this growing patient population.
引用
- Kim M, Lee EK, Kim KJ, et al. Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study. Thyroid. 2025. PMID: 41467912. doi:10.1177/10507256251409134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。